Literature DB >> 2014793

Recurrence risk of a new dominant mutation in children of unaffected parents.

E M Wijsman1.   

Abstract

Extensions to models originally described by Hartl for predicting the recurrence risk of new dominant mutations are developed in this paper. Additions to the models are (1) possible somatic mosaicism in a parent in some families, (2) the possibility that the parental origin of the mutation may or may not be known, and (3) mutation rates which change as a function of sex and/or time. The models indicate that recurrence risks are most critically affected by (a) the amount of somatic mosaicism which can be tolerated in the parent without manifesting disease and (b) knowledge of the parental origin of the mutation. In addition, there is a moderate effect on recurrence risks if mutation rates increase in the father as a function of time. Recurrence risks are at least as large as the risk of trisomy 21 in a child of a mother of age 35 years or older, probably much higher (5%-10%) when the mutation is known to be of maternal origin or if substantial somatic mosaicism in the parent is compatible with a normal phenotype. The recurrence risk of a new mutation is high because of a very high ascertainment bias of families with substantial germ-line mosaicism.

Entities:  

Mesh:

Year:  1991        PMID: 2014793      PMCID: PMC1682956     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

2.  Spontaneous mutation and parental age in humans.

Authors:  N Risch; E W Reich; M M Wishnick; J G McCarthy
Journal:  Am J Hum Genet       Date:  1987-08       Impact factor: 11.025

3.  Recurrence risks for germinal mosaics.

Authors:  D L Hartl
Journal:  Am J Hum Genet       Date:  1971-03       Impact factor: 11.025

Review 4.  Gonadal mosaicism in pseudoachondroplasia.

Authors:  J G Hall; J P Dorst; J Rotta; V A McKusick
Journal:  Am J Med Genet       Date:  1987-09

5.  Genetics of tuberous sclerosis.

Authors:  J G Hall; P H Byers
Journal:  Lancet       Date:  1987-03-28       Impact factor: 79.321

6.  Genetic counseling for autosomal dominant diseases with a negative family history.

Authors:  J M Friedman
Journal:  Clin Genet       Date:  1985-01       Impact factor: 4.438

7.  Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta.

Authors:  E M Thompson; I D Young; C M Hall; M E Pembrey
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

8.  Risk estimation in autosomal dominant disorders with reduced penetrance.

Authors:  A E Emery
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

9.  Achondroplasia: unexpected familial recurrence.

Authors:  C A Reiser; R M Pauli; J G Hall
Journal:  Am J Med Genet       Date:  1984-10

10.  Risk counselling in autosomal dominant disorders with undetermined penetrance.

Authors:  R M Pauli; A G Motulsky
Journal:  J Med Genet       Date:  1981-10       Impact factor: 6.318

View more
  11 in total

1.  Estimating mutation rate: how to count mutations?

Authors:  Yun-Xin Fu; Haying Huai
Journal:  Genetics       Date:  2003-06       Impact factor: 4.562

2.  A dominant mutation in the COL1A1 gene that substitutes glycine for valine causes recurrent lethal osteogenesis imperfecta.

Authors:  J Bonaventure; L Cohen-Solal; C Lasselin; P Maroteaux
Journal:  Hum Genet       Date:  1992-08       Impact factor: 4.132

3.  Germinal mosaicism and risk calculation in X-linked diseases.

Authors:  M Jeanpierre
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

4.  Recurrence risk for germinal mosaics revisited.

Authors:  M A van der Meulen; M J van der Meulen; G J te Meerman
Journal:  J Med Genet       Date:  1995-02       Impact factor: 6.318

5.  Frequency of somatic and germ-line mosaicism in retinoblastoma: implications for genetic counseling.

Authors:  K C Sippel; R E Fraioli; G D Smith; M E Schalkoff; J Sutherland; B L Gallie; T P Dryja
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

6.  Next generation sequencing in sporadic retinoblastoma patients reveals somatic mosaicism.

Authors:  Sara Amitrano; Annabella Marozza; Serena Somma; Valentina Imperatore; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Daniela Galimberti; Ilaria Meloni; Francesco Cetta; Pietro Piu; Chiara Di Marco; Laura Dosa; Caterina Lo Rizzo; Giulia Carignani; Maria Antonietta Mencarelli; Francesca Mari; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2015-02-25       Impact factor: 4.246

7.  Parental somatic and germ-line mosaicism for a multiexon deletion with unusual endpoints in a type III collagen (COL3A1) allele produces Ehlers-Danlos syndrome type IV in the heterozygous offspring.

Authors:  D M Milewicz; A M Witz; A C Smith; D K Manchester; G Waldstein; P H Byers
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

8.  Familial recurrences of FOXG1-related disorder: Evidence for mosaicism.

Authors:  Kelly Q McMahon; Apostolos Papandreou; Mandy Ma; Brenda J Barry; Ghayda M Mirzaa; William B Dobyns; Richard H Scott; Natalie Trump; Manju A Kurian; Alex R Paciorkowski
Journal:  Am J Med Genet A       Date:  2015-09-14       Impact factor: 2.802

9.  Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes.

Authors:  K Stephens; L Kayes; V M Riccardi; M Rising; V P Sybert; R A Pagon
Journal:  Hum Genet       Date:  1992-01       Impact factor: 4.132

10.  Mutation rates and the evolution of germline structure.

Authors:  Aylwyn Scally
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-07-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.